Revenio Group
30.06
EUR
-0.79 %
Corporate customer
REG1V
NASDAQ Helsinki
Medical Equipment & Services
Health Care
14,062 following
Income statement
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 26.8 | 30.7 | 49.5 | 61.1 | 78.8 | 97.0 | 96.6 | 105.2 | 119.4 | 138.8 | 159.4 |
growth-% | 14.6 % | 61.4 % | 23.4 % | 29.0 % | 23.1 % | -0.4 % | 8.9 % | 13.4 % | 16.3 % | 14.8 % | |
EBITDA | 10.2 | 10.7 | 14.6 | 21.7 | 25.7 | 33.1 | 30.3 | 30.8 | 37.4 | 47.1 | 54.7 |
EBIT (adj.) | 9.5 | 10.2 | 15.6 | 19.2 | 24.5 | 30.9 | 28.5 | 27.5 | 34.2 | 42.8 | 50.7 |
EBIT | 8.1 | 10.2 | 12.6 | 17.1 | 22.1 | 29.7 | 26.3 | 25.7 | 33.2 | 41.8 | 49.8 |
Profit before taxes | 8.3 | 10.3 | 12.3 | 16.7 | 22.1 | 29.1 | 25.4 | 25.4 | 33.4 | 42.6 | 51.2 |
Net income | 6.8 | 8.1 | 9.4 | 13.4 | 17.3 | 21.8 | 19.1 | 19.0 | 25.8 | 32.8 | 39.4 |
EPS (adj.) | 0.30 | 0.34 | 0.47 | 0.58 | 0.74 | 0.86 | 0.80 | 0.78 | 1.01 | 1.27 | 1.52 |
growth-% | 14.0 % | 39.4 % | 22.8 % | 27.0 % | 16.9 % | -7.4 % | -2.0 % | 28.4 % | 26.0 % | 19.4 % | |
Dividend | 0.26 | 0.28 | 0.30 | 0.32 | 0.34 | 0.36 | 0.38 | 0.37 | 0.52 | 0.69 | 0.89 |
Dividend ratio | 90.9 % | 82.3 % | 85.1 % | 63.6 % | 52.4 % | 43.9 % | 52.9 % | 52.0 % | 54.0 % | 56.0 % | 60.0 % |
Profitability and return on capital
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|---|---|---|
EBITDA-% | 38.1 % | 35.0 % | 29.5 % | 35.5 % | 32.7 % | 34.1 % | 31.4 % | 29.3 % | 31.3 % | 34.0 % | 34.3 % |
EBIT-% (adj.) | 35.5 % | 33.3 % | 31.5 % | 31.5 % | 31.1 % | 31.8 % | 29.5 % | 26.2 % | 28.7 % | 30.8 % | 31.8 % |
EBIT-% | 30.3 % | 33.3 % | 25.5 % | 28.1 % | 28.1 % | 30.6 % | 27.3 % | 24.4 % | 27.8 % | 30.1 % | 31.2 % |
ROE | 47.8 % | 22.7 % | 20.0 % | 23.4 % | 25.7 % | 20.0 % | 18.2 % | 22.1 % | 24.4 % | 25.6 % | |
ROI | 58.8 % | 22.4 % | 18.0 % | 22.1 % | 27.6 % | 23.3 % | 21.7 % | 26.3 % | 29.8 % | 31.4 % |
Valuation
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|---|---|---|
Share price (EUR) | 12.00 | 12.56 | 26.25 | 50.30 | 55.55 | 38.60 | 25.20 | 30.06 | 30.06 | 30.06 | 30.06 |
Shares | 23.9 | 23.9 | 26.5 | 26.6 | 26.7 | 26.6 | 26.6 | 26.6 | 26.6 | 26.6 | 26.6 |
Market cap | 287.3 | 300.7 | 696.8 | 1,336.9 | 1,482.1 | 1,026.0 | 669.8 | 799.0 | 799.0 | 799.0 | 799.0 |
Enterprise value | 279.5 | 290.5 | 699.7 | 1,334.9 | 1,482.0 | 1,014.6 | 666.8 | 792.1 | 773.5 | 749.5 | 724.3 |
EV/S | 10.4 | 9.5 | 14.1 | 21.9 | 18.8 | 10.5 | 6.9 | 7.5 | 6.5 | 5.4 | 4.5 |
EV/EBITDA | 27.4 | 27.1 | 47.9 | 61.5 | 57.6 | 30.6 | 22.0 | 25.7 | 20.7 | 15.9 | 13.2 |
EV/EBIT (adj.) | 29.4 | 28.5 | 44.9 | 69.4 | 60.4 | 32.9 | 23.4 | 28.8 | 22.6 | 17.5 | 14.3 |
EV/EBIT | 34.5 | 28.5 | 55.6 | 77.9 | 67.1 | 34.2 | 25.3 | 30.8 | 23.3 | 17.9 | 14.5 |
P/E (adj.) | 40.2 | 36.9 | 55.4 | 86.4 | 75.1 | 44.6 | 31.5 | 38.3 | 29.8 | 23.7 | 19.8 |
P/E | 42.0 | 36.9 | 73.0 | 99.9 | 85.7 | 47.1 | 35.1 | 42.0 | 31.0 | 24.4 | 20.3 |
P/B | 18.0 | 16.6 | 10.8 | 19.2 | 18.9 | 11.3 | 6.7 | 7.3 | 6.4 | 5.6 | 4.9 |
P/S | 10.7 | 9.8 | 14.1 | 21.9 | 18.8 | 10.6 | 6.9 | 7.6 | 6.7 | 5.8 | 5.0 |
Dividend yield | 2.2 % | 2.2 % | 1.1 % | 0.6 % | 0.6 % | 0.9 % | 1.5 % | 1.2 % | 1.7 % | 2.3 % | 3.0 % |
Equity ratio | 84.0 % | 81.9 % | 58.6 % | 60.9 % | 63.0 % | 66.8 % | 72.7 % | 75.7 % | 78.5 % | 78.7 % | 78.2 % |
Gearing ratio | -48.4 % | -55.8 % | 4.7 % | -2.7 % | -12.5 % | -2.9 % | -6.2 % | -20.4 % | -34.4 % | -45.3 % |
Quarter data
Q4/23 | 2023 | Q1/24 | Q2/24 | Q3/24 | Q4/24e | 2024e | Q1/25e | Q2/25e | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 29.1 | 96.6 | 23.6 | 25.4 | 23.9 | 32.2 | 105.2 | 26.5 | 29.9 |
EBITDA | 10.5 | 30.3 | 6.2 | 7.1 | 6.7 | 10.8 | 30.8 | 7.1 | 8.8 |
EBIT | 9.5 | 26.3 | 5.1 | 5.3 | 5.5 | 9.8 | 25.7 | 6.0 | 7.7 |
Profit before taxes | 9.2 | 25.4 | 4.8 | 5.5 | 5.4 | 9.7 | 25.4 | 6.0 | 7.7 |
Net income | 7.1 | 19.1 | 3.6 | 4.1 | 3.8 | 7.5 | 19.0 | 4.6 | 5.9 |